SKIN (SkinHealth Systems Inc. Class A Common Stock) Stock Analysis - Insider Trades

SkinHealth Systems Inc. Class A Common Stock (SKIN) is a publicly traded Consumer Defensive sector company. As of May 21, 2026, SKIN trades at $0.69 with a market cap of $78.49M and a P/E ratio of -13.92. SKIN moved +4.00% today. Year to date, SKIN is -51.95%; over the trailing twelve months it is -59.91%. Its 52-week range spans $0.55 to $2.69. Analyst consensus is neutral with an average price target of $1.63. Rallies surfaces SKIN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading SKIN stock inside the company?

Recent SKIN insider activity includes Gruber Desiree sold 14.66K and SAUNDERS BRENT L bought 40.45K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

SKIN Key Metrics

Key financial metrics for SKIN
MetricValue
Price$0.69
Market Cap$78.49M
P/E Ratio-13.92
EPS$-0.05
Dividend Yield0.00%
52-Week High$2.69
52-Week Low$0.55
Volume1
Avg Volume0
Revenue (TTM)$296.12M
Net Income$-6.05M
Gross Margin64.91%

Recent SKIN Insider Trades

  • Gruber Desiree sold 14.66K (~$22.02K) on Nov 20, 2024.
  • SAUNDERS BRENT L bought 40.45K (~$43.69K) on Aug 12, 2024.

Latest SKIN News

SKIN Analyst Consensus

5 analysts cover SKIN: 0 strong buy, 1 buy, 3 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $1.63.

Common questions about SKIN

Who is trading SKIN stock inside the company?
Recent SKIN insider activity includes Gruber Desiree sold 14.66K and SAUNDERS BRENT L bought 40.45K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for SKIN?
Yes. Rallies tracks SKIN insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is SKIN research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SKIN. It does not provide personalized investment advice.
SKIN

SKIN